Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
169 people get CPIX articles and Market Currents by email alert.
Get email alerts on CPIX »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
Trading FDA, Clinical Trial Binary Events: Cumberland PharmaMike Havrilla • Sun, Jul 11, 2010 -
Cumberland: Encouraging Ibuprofen DataZacks Investment Research • Thu, Apr 15, 2010 -
Cumberland Pharmaceuticals Beats Estimates in Third QuarterZacks Investment Research • Mon, Nov 30, 2009
-
Cumberland Pharmaceuticals Prices IPO After a Two Year WaitSA Editor Abbi Adest • Tue, Aug 11, 2009
-
3 Healthcare Stocks With Minimal Debt, Predicted For GrowthZetaKap • Thu, Oct 25, 2012 -
-
-
-
-
-
-
Top 10 Stocks With Strong Balance Sheet And Price Performance In 2012StockPandit • Fri, Apr 27, 2012 -
5 Picks To Beat Valeant PharmaceuticalsStocks & Shares • Tue, Mar 20, 2012 -
-
7 Healthcare Stocks Undervalued By Earnings Growth And Cash FlowsKapitall • Fri, Feb 3, 2012
-
-
-
-
-
-
-
6 Undervalued Healthcare Stocks With Impressive ProfitabilityKapitall • Wed, Sep 14, 2011
-
9 Undervalued Small Caps Correlated With Market VolatilityKapitall • Wed, Aug 17, 2011
-
-
PR Newswire (Jun 10, 2013)
-
PR Newswire (May 15, 2013)
-
PR Newswire (May 2, 2013)
-
PR Newswire (Apr 25, 2013)
-
PR Newswire (Feb 28, 2013)
-
PR Newswire (Feb 19, 2013)
-
PR Newswire (Feb 14, 2013)
-
PR Newswire (Nov 7, 2012)
-
PR Newswire (Nov 1, 2012)
-
PR Newswire (Oct 18, 2012)
-
PR Newswire (Sep 19, 2012)
-
PR Newswire (Sep 6, 2012)
-
PR Newswire (Aug 2, 2012)
-
PR Newswire (Jul 12, 2012)
-
PR Newswire (Jun 13, 2012)
-
PR Newswire (May 3, 2012)
-
PR Newswire (Apr 12, 2012)
-
PR Newswire (Mar 27, 2012)
CPIX vs. ETF Alternatives
Company Description
Currently, there's no company description for CPIX.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, May 2, 7:19 PM Cumberland Pharmaceuticals (CPIX): Q1 EPS of $0.05 in-line. Revenue of $10.3M beats by $0.3M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Thursday, February 28, 4:52 PM Cumberland Pharmaceuticals (CPIX): Q4 EPS of $0.09 misses by $0.05. Revenue of $13.7M misses by $0.17M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Tuesday, January 29, 2:53 PM Cumberland Pharmaceuticals (CPIX +3.4%) gains today after it enters into an exclusive agreement with Indonesia's SOHO Industri Pharmasi for the Indonesian marketing of its of Caldolor Injection, which is used to treat pain and fever in hospitals. The deal gives SOHO an exclusive license, leaving it responsible for regulatory approval, reporting, product marketing, distribution and sales once approved. In exchange, CPIX will receive upfront and milestone payments, as well as transfer prices on future drug sales. Comment! [Healthcare, On the Move]
- Friday, November 30, 2012, 5:42 PM Cumberland Pharmaceuticals (CPIX) announces a realignment of its national sales organization in the U.S. As a result, the company’s sales staff has been reduced from 95 to 64 individuals and its number of nationwide districts has been consolidated from 10 to 8. The company expects to incur between $500,00 and $750,000 in one-time related separation expenses during Q4. The impact on earnings will be addressed in its 2013 guidance. Comment! [Healthcare]
-
Friday, November 9, 2012, 9:10 AM
Premarket gainers: ZIP +27%. KYAK +26%. LGF +9%. ENR +8%. PSTI +8%. IGT +7%. WCRX +6%. ISIS +5%.
Losers: GRPN -23%. MTG -15%. ARRY -12%. PGRX -12%. SPRD -10%. JCP -8%. PVR -6%. CPIX -5%. DIS -5%. 1 Comment [On the Move] - Thursday, November 1, 2012, 6:51 PM Cumberland Pharmaceuticals (CPIX): Q3 EPS of $0.10 beats by $0.01. Revenue of $12.5M (-4.5% Y/Y) misses by $0.5M. (PR) Comment! [Earnings, Healthcare]
- Thursday, August 2, 2012, 5:26 PM Cumberland Pharmaceuticals (CPIX): Q2 EPS of $0.09 beats by $0.02. Revenue of $12.4M (-12.5% Y/Y) misses by $0.3M. (PR) Comment! [Earnings, Healthcare]
- Thursday, May 3, 2012, 5:58 PM Cumberland Pharma (CPIX): Q1 EPS of $0.02 misses by $0.03. Revenue of $10.3M (-3.9% Y/Y) misses by $2.5M. (PR) Comment! [Earnings, Healthcare]
- Tuesday, February 21, 2012, 11:37 AM Cumberland Pharmaceuticals (CPIX +0.8%) gets a boost from an upgrade to Outperform at Wells Fargo on expectations management will make Acetadote its priority and de-emphasize Caldolor. The firm also raises its target range to $9 - $11 from $7 - $9. Comment! [Healthcare]
- Thursday, February 9, 2012, 8:53 AM Cumberland Pharmaceuticals (CPIX) says a new formulation of Acetadote, its drug injected to treat acetaminophen poisoning, received a notice of allowance from the U.S. patent office. The new formulation does not contain ethylene diamine tetracetic acid, in keeping with an FDA request, and has a longer shelf life of 30 months. (PR) Comment! [Healthcare]
- Tuesday, August 11, 2009, 11:06 AM After a two-year wait, shares of Cumberland Pharma (CPIX) finally begin trading at $17, right where they priced. It marks the first pharma IPO since Nov. 2007. Abbi Adest has the overview. Comment!
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.